Atlas Trials

Characteristics and Mechanism of Denosumab-treated Giant Cell Tumor of Bone

Clinical trial NCT03259152 · UNKNOWN

Trial details

NCT number
NCT03259152
Sponsor
Hebei Medical University Third Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Giant Cell Tumor of Bone
Start date
2016-05-01
Primary completion
2019-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.